{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:58:12Z","timestamp":1773741492025,"version":"3.50.1"},"reference-count":32,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,5]]},"abstract":"<jats:p>Human immunodeficiency virus\/tuberculosis (HIV\/TB) coinfection is particularly prevalent in South Africa, where TB has been the leading cause of death for more than a decade. The 2004\u20132008 national rollout of antiretroviral therapy (ART) provides a unique opportunity to examine the population-level impact of ART on the TB epidemic. We performed longitudinal regression analysis to follow the evolution of TB outcomes before and after the introduction of ART using a large data set from the National Health Laboratory Service. This is the first study to produce estimates of the impact of the ART rollout by exploiting staggered timing and geographic variation in the rollout. After ART became available in a health facility, 3.7% (<jats:italic>P<\/jats:italic> &lt; 0.0001) more patients were tested for TB and 3.2% (<jats:italic>P<\/jats:italic> &lt; 0.0001) more received repeat testing; however, there was a steep rise in testing before the introduction of ART. Although the number of TB-positive patients increased by 4.3% (<jats:italic>P<\/jats:italic> = 0.0002) in the first year post-ART, the TB rate among tested patients fell by 2 percentage points (8%, <jats:italic>P<\/jats:italic> = 0.001) after 2 years. Sputum smear testing declined relative to more technologically advanced diagnostics post-ART. Antiretroviral therapy availability increased the attention to TB screening and drew new patients into the health-care system. Small increases in the numbers of repeat patients are indicative of retention in care. The decline in TB rates post-ART suggests that the reduction in TB risk due to improved immune functioning and health-care contact likely outweighed the increased TB risk because of the longer lifespan of ART initiators.<\/jats:p>","DOI":"10.4269\/ajtmh.17-0530","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T07:00:26Z","timestamp":1538463626000},"page":"1407-1414","source":"Crossref","is-referenced-by-count":7,"title":["The Impact of Anti-Retroviral Therapy on Tuberculosis Detection at the National Level in South Africa"],"prefix":"10.4269","volume":"99","author":[{"given":"Zo\u00eb M.","family":"McLaren","sequence":"first","affiliation":[{"name":"Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana","family":"Sharp","sequence":"additional","affiliation":[{"name":"Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Brouwer","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananta","family":"Nanoo","sequence":"additional","affiliation":[{"name":"Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","series-title":"J Infect Dis","first-page":"150","article-title":"How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners","volume":"191","author":"Sonnenberg","year":"2005"},{"key":"b2","series-title":"Clin Infect Dis","first-page":"S201","article-title":"HIV infection-associated tuberculosis: the epidemiology and the response","volume":"50","author":"Getahun","year":"2010"},{"key":"b3","author":"WHO","year":"2017"},{"key":"b4","author":"Statistics South Africa","year":"2013"},{"key":"b5","series-title":"Science","first-page":"961","article-title":"Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment","volume":"339","author":"Bor","year":"2013"},{"key":"b6","series-title":"Lancet Infect Dis","first-page":"1066","article-title":"Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004\u201312: a time series analysis","volume":"15","author":"Nanoo","year":"2015"},{"key":"b7","series-title":"Health Policy Plan","first-page":"1162","article-title":"Equity in the national rollout of public AIDS treatment in South Africa 2004\u201308","volume":"30","author":"McLaren","year":"2015"},{"key":"b8","series-title":"South Afr J HIV Med","first-page":"22","article-title":"Access to antiretroviral treatment in South Africa, 2004\u20132011","volume":"13","author":"Johnson","year":"2012"},{"key":"b9","series-title":"JAMA","first-page":"423","article-title":"Opportunities and challenges for HIV care in overlapping HIV and TB epidemics","volume":"300","author":"Havlir","year":"2008"},{"key":"b10","series-title":"N Engl J Med","first-page":"1492","article-title":"Integration of antiretroviral therapy with tuberculosis treatment","volume":"365","author":"Abdool Karim","year":"2011"},{"key":"b11","series-title":"Int J Tuberc Lung Dis","first-page":"571","article-title":"Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?","volume":"15","author":"Lawn","year":"2011"},{"key":"b12","series-title":"Lancet","first-page":"921","article-title":"HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response","volume":"374","author":"Karim","year":"2009"},{"key":"b13","series-title":"Trop Med Int Health","first-page":"171","article-title":"Assessing healthcare quality using routine data: evaluating the performance of the national tuberculosis programme in South Africa","volume":"22","author":"McLaren","year":"2017"},{"key":"b14","series-title":"Curr HIV Res","first-page":"383","article-title":"Antiretroviral treatment as prevention: impact of the \u2018test and treat\u2019 strategy on the tuberculosis epidemic","volume":"9","author":"Wood","year":"2011"},{"key":"b15","series-title":"Clin Infect Dis","first-page":"1772","article-title":"Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America","volume":"41","author":"Girardi","year":"2005"},{"key":"b16","series-title":"Am J Respir Crit Care Med","first-page":"1080","article-title":"Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township","volume":"182","author":"Middelkoop","year":"2010"},{"key":"b17","series-title":"AIDS","first-page":"S25","article-title":"The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models","volume":"28","author":"Pretorius","year":"2014"},{"key":"b18","series-title":"PLoS Med","first-page":"e1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis","volume":"9","author":"Suthar","year":"2012"},{"key":"b19","series-title":"Proc Natl Acad Sci USA","first-page":"19485","article-title":"Antiretroviral therapy for tuberculosis control in nine African countries","volume":"107","author":"Williams","year":"2010"},{"key":"b20","series-title":"Clin Infect Dis","first-page":"823","article-title":"Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa","volume":"51","author":"Bassett","year":"2010"},{"key":"b21","series-title":"Int J Tuberc Lung Dis","first-page":"933","article-title":"Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi","volume":"15","author":"Zachariah","year":"2011"},{"key":"b22","series-title":"J Acquir Immune Defic Syndr","first-page":"42","article-title":"Survival rate and risk factors of mortality among HIV\/tuberculosis-coinfected patients with and without antiretroviral therapy","volume":"43","author":"Manosuthi","year":"2006"},{"key":"b23","series-title":"J Infect Dis","first-page":"491","article-title":"The survival benefits of antiretroviral therapy in South Africa","volume":"209","author":"April","year":"2014"},{"key":"b24","author":"National Treasury South Africa","year":"2007"},{"key":"b25","series-title":"PLoS One","first-page":"e36966","article-title":"The impact and cost of scaling up GeneXpert MTB\/RIF in South Africa","volume":"7","author":"Meyer-Rath","year":"2012"},{"key":"b26","series-title":"J Int Assoc Physicians AIDS Care (Chic)","first-page":"200","article-title":"Characteristics of patients accessing care and treatment for HIV\/AIDS at public and nongovernmental sites in South Africa","volume":"7","author":"Rosen","year":"2008"},{"key":"b27","author":"World Health Organization","year":"2008"},{"key":"b28","series-title":"AIDS","first-page":"2233","article-title":"The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting","volume":"26","author":"Houben","year":"2012"},{"key":"b29","series-title":"PLoS One","first-page":"e75466","article-title":"Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis","volume":"8","author":"Dodd","year":"2013"},{"key":"b30","series-title":"BMC Public Health","first-page":"63","article-title":"Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in southern Africa: a systematic review","volume":"7","author":"Muula","year":"2007"},{"key":"b31","series-title":"BMC Public Health","first-page":"387","article-title":"Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation","volume":"10","author":"Wouters","year":"2010"},{"key":"b32","series-title":"Lancet Infect Dis","first-page":"173","article-title":"Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings","volume":"9","author":"Reid","year":"2009"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/99\/6\/article-p1407.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/99\/6\/article-p1407.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/99\/6\/article-p1407.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T20:36:06Z","timestamp":1722458166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/99\/6\/article-p1407.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":32,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.17-0530","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]}}}